Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-005637

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Sep 1, 2016P18,214$6.51A65,580IBy: Separately Managed Account
Common StockF1,F4Sep 2, 2016P471$6.51A66,051IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses